Search research articles
Contact Us
Filters
Showing results (671-680 of 832) with videos related to
Page
of 84
Sort By:
Molecular Neurodegeneration
|
November 12, 2010
NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration
Young-Don Kwak, Tao Ma, Shiyong Diao, et al.
Molecular Neurobiology
|
October 5, 2013
Potential effect of S-nitrosylated protein disulfide isomerase on mutant SOD1 aggregation and neuronal cell death in amyotrophic lateral sclerosis
Gye Sun Jeon, Tomohiro Nakamura, Jeong-Seon Lee, et al.
The Journal of Biological Chemistry
|
January 16, 2007
Neuronal apoptotic signaling pathways probed and intervened by synthetically and modularly modified (SMM) chemokines
Won-Tak Choi, Marcus Kaul, Santosh Kumar, et al.
Cancer
|
February 15, 1987
Aromatase activity in primary and metastatic human breast cancer
A Lipton, S J Santner, R J Santen, et al.
The New England Journal of Medicine
|
December 12, 1996
Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group
G N Hortobagyi, R L Theriault, L Porter, et al.
Journal of Psychiatric Research
|
September 1, 1972
Thyroid-imipramine clinical and chemical interaction: evidence for a receptor deficit in depression
A J Prange, I C Wilson, A E Knox, et al.
Neuropsychobiology
|
January 1, 1975
Parameters of alteration of pentobarbital response by hypothalamic polypeptides
A J Prange, G R Breese, G D Jahnke, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
May 22, 2024
Single-Cell Patch-Clamp/Proteomics of Human Alzheimer's Disease iPSC-Derived Excitatory Neurons Versus Isogenic Wild-Type Controls Suggests Novel Causation and Therapeutic Targets
Swagata Ghatak, Jolene K Diedrich, Maria Talantova, et al.
Anticancer Research
|
March 1, 1986
Hormone stimulation and chemotherapy in advanced prostate cancer: interim analysis of an ongoing randomized trial
A Manni, R J Santen, A E Boucher, et al.
Journal of Biological Response Modifiers
|
June 1, 1988
A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancy
R Perez, A Lipton, H A Harvey, et al.
Page
of 84
Search research articles
Search
Showing results (671-680 of 832) with videos related to
Sort By:
Page
of 84
Molecular Neurodegeneration
|
November 12, 2010
NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration
Young-Don Kwak, Tao Ma, Shiyong Diao, et al.
Molecular Neurobiology
|
October 5, 2013
Potential effect of S-nitrosylated protein disulfide isomerase on mutant SOD1 aggregation and neuronal cell death in amyotrophic lateral sclerosis
Gye Sun Jeon, Tomohiro Nakamura, Jeong-Seon Lee, et al.
The Journal of Biological Chemistry
|
January 16, 2007
Neuronal apoptotic signaling pathways probed and intervened by synthetically and modularly modified (SMM) chemokines
Won-Tak Choi, Marcus Kaul, Santosh Kumar, et al.
Cancer
|
February 15, 1987
Aromatase activity in primary and metastatic human breast cancer
A Lipton, S J Santner, R J Santen, et al.
The New England Journal of Medicine
|
December 12, 1996
Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group
G N Hortobagyi, R L Theriault, L Porter, et al.
Journal of Psychiatric Research
|
September 1, 1972
Thyroid-imipramine clinical and chemical interaction: evidence for a receptor deficit in depression
A J Prange, I C Wilson, A E Knox, et al.
Neuropsychobiology
|
January 1, 1975
Parameters of alteration of pentobarbital response by hypothalamic polypeptides
A J Prange, G R Breese, G D Jahnke, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
May 22, 2024
Single-Cell Patch-Clamp/Proteomics of Human Alzheimer's Disease iPSC-Derived Excitatory Neurons Versus Isogenic Wild-Type Controls Suggests Novel Causation and Therapeutic Targets
Swagata Ghatak, Jolene K Diedrich, Maria Talantova, et al.
Anticancer Research
|
March 1, 1986
Hormone stimulation and chemotherapy in advanced prostate cancer: interim analysis of an ongoing randomized trial
A Manni, R J Santen, A E Boucher, et al.
Journal of Biological Response Modifiers
|
June 1, 1988
A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancy
R Perez, A Lipton, H A Harvey, et al.
Page
of 84